Tilray Stock Pops on New Trump-Driven Cannabis Hopes. Should You Chase the Rally?
Tilray shares rally as Trump urges the DOJ to quickly reclassify cannabis as a Schedule III drug. Options pricing suggests TLRY stock could rip higher…
Tilray Brands (TLRY) stock closed meaningfully higher on Monday after President Donald Trump urged the DOJ, during an Oval Office event, to expeditiously reclassify cannabis as a Schedule III drug.
…